Schedule 13G ownership disclosure
Janux Therapeutics Inc
Security class unavailable · CUSIP: 47103J105
Event date: 2021-06-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-199391
- Form type
- SC 13G
- Filer
- Bregua Corp
- CIK
- CIK 1863287
- Filed
- Jun 25, 2021
- Reporting period
- Jun 15, 2021
- Description
- Schedule 13G beneficial ownership